Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa
Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with MDR-TB alon...
Saved in:
| Published in: | Journal of acquired immune deficiency syndromes (1999) Vol. 82; no. 2; p. 124 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.10.2019
|
| Subjects: | |
| ISSN: | 1944-7884, 1944-7884 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with MDR-TB alone to determine the impact of concurrent treatment on adherence and outcomes.
We assessed medication adherence monthly using 3-day recall, 30-day recall, and visual analog scale and examined adherence to monthly study visits (months 0-12). We determined the proportion of participants fully adherent (no reported missed doses) to MDR-TB vs. HIV treatment by each measure. We assessed the association of medication and clinic visit adherence with MDR-TB treatment success (cure or completion, 18-24 months) and HIV virologic suppression.
Among 200 patients with MDR-TB, 63% were women, median age was 33 years, 144 (72%) were HIV-infected, and 81% were receiving antiretroviral therapy (ART) at baseline. Adherence to medications (81%-98% fully adherent across all measures) and clinic visits (80% missed ≤1 visit) was high, irrespective of HIV status. Adherence to ART was significantly higher than to MDR-TB treatment by all self-reported measures (3-day recall: 92% vs. 84%, respectively; P = 0.003). In multivariable analysis, the adjusted risk ratio of unsuccessful MDR-TB treatment increased with every missed visit: 1.50, 2.25, and 3.37 for unsuccessful treatment, for 1, 2, and ≥3 missed visits.
Adherence to ART was higher than to MDR-TB treatment among persons with MDR-TB/HIV coinfection. Missed clinic visits may be a simple measure for identifying patients at risk of unsuccessful MDR-TB treatment outcome. |
|---|---|
| AbstractList | Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with MDR-TB alone to determine the impact of concurrent treatment on adherence and outcomes.
We assessed medication adherence monthly using 3-day recall, 30-day recall, and visual analog scale and examined adherence to monthly study visits (months 0-12). We determined the proportion of participants fully adherent (no reported missed doses) to MDR-TB vs. HIV treatment by each measure. We assessed the association of medication and clinic visit adherence with MDR-TB treatment success (cure or completion, 18-24 months) and HIV virologic suppression.
Among 200 patients with MDR-TB, 63% were women, median age was 33 years, 144 (72%) were HIV-infected, and 81% were receiving antiretroviral therapy (ART) at baseline. Adherence to medications (81%-98% fully adherent across all measures) and clinic visits (80% missed ≤1 visit) was high, irrespective of HIV status. Adherence to ART was significantly higher than to MDR-TB treatment by all self-reported measures (3-day recall: 92% vs. 84%, respectively; P = 0.003). In multivariable analysis, the adjusted risk ratio of unsuccessful MDR-TB treatment increased with every missed visit: 1.50, 2.25, and 3.37 for unsuccessful treatment, for 1, 2, and ≥3 missed visits.
Adherence to ART was higher than to MDR-TB treatment among persons with MDR-TB/HIV coinfection. Missed clinic visits may be a simple measure for identifying patients at risk of unsuccessful MDR-TB treatment outcome. Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with MDR-TB alone to determine the impact of concurrent treatment on adherence and outcomes.BACKGROUNDSuccess in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with MDR-TB alone to determine the impact of concurrent treatment on adherence and outcomes.We assessed medication adherence monthly using 3-day recall, 30-day recall, and visual analog scale and examined adherence to monthly study visits (months 0-12). We determined the proportion of participants fully adherent (no reported missed doses) to MDR-TB vs. HIV treatment by each measure. We assessed the association of medication and clinic visit adherence with MDR-TB treatment success (cure or completion, 18-24 months) and HIV virologic suppression.METHODSWe assessed medication adherence monthly using 3-day recall, 30-day recall, and visual analog scale and examined adherence to monthly study visits (months 0-12). We determined the proportion of participants fully adherent (no reported missed doses) to MDR-TB vs. HIV treatment by each measure. We assessed the association of medication and clinic visit adherence with MDR-TB treatment success (cure or completion, 18-24 months) and HIV virologic suppression.Among 200 patients with MDR-TB, 63% were women, median age was 33 years, 144 (72%) were HIV-infected, and 81% were receiving antiretroviral therapy (ART) at baseline. Adherence to medications (81%-98% fully adherent across all measures) and clinic visits (80% missed ≤1 visit) was high, irrespective of HIV status. Adherence to ART was significantly higher than to MDR-TB treatment by all self-reported measures (3-day recall: 92% vs. 84%, respectively; P = 0.003). In multivariable analysis, the adjusted risk ratio of unsuccessful MDR-TB treatment increased with every missed visit: 1.50, 2.25, and 3.37 for unsuccessful treatment, for 1, 2, and ≥3 missed visits.RESULTSAmong 200 patients with MDR-TB, 63% were women, median age was 33 years, 144 (72%) were HIV-infected, and 81% were receiving antiretroviral therapy (ART) at baseline. Adherence to medications (81%-98% fully adherent across all measures) and clinic visits (80% missed ≤1 visit) was high, irrespective of HIV status. Adherence to ART was significantly higher than to MDR-TB treatment by all self-reported measures (3-day recall: 92% vs. 84%, respectively; P = 0.003). In multivariable analysis, the adjusted risk ratio of unsuccessful MDR-TB treatment increased with every missed visit: 1.50, 2.25, and 3.37 for unsuccessful treatment, for 1, 2, and ≥3 missed visits.Adherence to ART was higher than to MDR-TB treatment among persons with MDR-TB/HIV coinfection. Missed clinic visits may be a simple measure for identifying patients at risk of unsuccessful MDR-TB treatment outcome.CONCLUSIONSAdherence to ART was higher than to MDR-TB treatment among persons with MDR-TB/HIV coinfection. Missed clinic visits may be a simple measure for identifying patients at risk of unsuccessful MDR-TB treatment outcome. |
| Author | Moodley, Pravi Mlisana, Koleka Allana, Salim Shah, Sarita Gandhi, Neel R Stephens, Fay Brust, James C M Campbell, Angie |
| Author_xml | – sequence: 1 givenname: Fay surname: Stephens fullname: Stephens, Fay organization: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA – sequence: 2 givenname: Neel R surname: Gandhi fullname: Gandhi, Neel R organization: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA – sequence: 3 givenname: James C M surname: Brust fullname: Brust, James C M organization: Divisions of General Internal Medicine & Infectious Diseases, Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, NY – sequence: 4 givenname: Koleka surname: Mlisana fullname: Mlisana, Koleka organization: Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa – sequence: 5 givenname: Pravi surname: Moodley fullname: Moodley, Pravi organization: Department of Virology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa – sequence: 6 givenname: Salim surname: Allana fullname: Allana, Salim organization: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA – sequence: 7 givenname: Angie surname: Campbell fullname: Campbell, Angie organization: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA – sequence: 8 givenname: Sarita surname: Shah fullname: Shah, Sarita organization: Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31513073$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtOwzAQRS1URB_wBwh5yYKUOLYbZxlVQCvKqxQWbCLXnrRBiVPsGMQf8NmkAkRnM6Ojo6uZ6aOOqQ0gdEzCIQmT-PwhnQ7DnYpIFO6hHkkYC2IhWGdn7qK-c69hSEaMJQeoSwknNIxpD30tLMimAtPgVK_BglGA06o2K3wP1tXG4TkoKN6Lloxro7y1W_nGl02hrV8Fc3CFa2TLFn4JVvmybgGWRuPJ9Bn_5xcGX3_IF1_64FY2sjzDj7Vv1jjNbaHkIdrPZeng6LcP0NPlxWI8CWZ3V9NxOgsUi0Y04FwqKkTOaXtAznVOBQWahHFOFB_FCdWEa7LUSsWxVLkkOWPt_kyI1haSRAN0-pO7sfWbB9dkVeEUlKU0UHuXRZFIeMwjtlVPflW_rEBnG1tU0n5mf9-LvgFQSnXG |
| CitedBy_id | crossref_primary_10_3390_life11060528 crossref_primary_10_1177_00185787231224065 crossref_primary_10_36303_SAGP_1204 crossref_primary_10_1093_cid_ciae145 crossref_primary_10_3390_jcm9113575 crossref_primary_10_1007_s00203_025_04415_y crossref_primary_10_1016_j_ijregi_2025_100647 crossref_primary_10_1183_13993003_00837_2020 crossref_primary_10_1097_JNC_0000000000000242 crossref_primary_10_21292_2075_1230_2022_100_11_56_65 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/QAI.0000000000002120 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1944-7884 |
| ExternalDocumentID | 31513073 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: K23 AI083088 – fundername: NIAID NIH HHS grantid: P30 AI050409 – fundername: NIAID NIH HHS grantid: R01 AI089349 – fundername: NCATS NIH HHS grantid: UL1 TR000454 – fundername: NCATS NIH HHS grantid: UL1 TR001073 – fundername: NIAID NIH HHS grantid: P30 AI124414 – fundername: NIAID NIH HHS grantid: R01 AI114304 – fundername: NIAID NIH HHS grantid: R01 AI087465 – fundername: NIAID NIH HHS grantid: K24 AI114444 – fundername: NIAID NIH HHS grantid: U19 AI111211 |
| GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 1J1 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 77Y 7O~ 8L- AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAQKA AARTV AASCR AASOK AASXQ AAXQO ABASU ABBUW ABDIG ABIVO ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACPRK ACWDW ACWRI ACXJB ACXNZ ADGGA ADHPY AE3 AE6 AEBDS AFDTB AFEXH AFRAH AFUWQ AGINI AHMBA AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BKOMP BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM E.X EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRJ FRP GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI L-C NPM N~7 N~B O9- OAG OAH ODA ODMTH OHH OHYEH OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OWV OWX OWY OWZ OXXIT P2P PQQKQ RIG RLZ RXW S4R S4S TAE TEORI TSPGW V2I VVN W2D W3M WOQ WOW X3V X3W XYM YOC 7X8 ABPXF ABXYN ABZZY ACZKN ADKSD ADSXY AFBFQ AFNMH AHQVU AOQMC |
| ID | FETCH-LOGICAL-c4263-55ac388f53130f5df383e3907f1c56793d15d1bdcc77acfa1f44ece4880f58a12 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 11 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000509681700013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1944-7884 |
| IngestDate | Mon Sep 08 05:47:39 EDT 2025 Wed Feb 19 02:30:43 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4263-55ac388f53130f5df383e3907f1c56793d15d1bdcc77acfa1f44ece4880f58a12 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6760842 |
| PMID | 31513073 |
| PQID | 2289575241 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2289575241 pubmed_primary_31513073 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-10-01 20191001 |
| PublicationDateYYYYMMDD | 2019-10-01 |
| PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of acquired immune deficiency syndromes (1999) |
| PublicationTitleAlternate | J Acquir Immune Defic Syndr |
| PublicationYear | 2019 |
| SSID | ssj0016449 |
| Score | 2.3630743 |
| Snippet | Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 124 |
| SubjectTerms | Adult Female HIV Infections - drug therapy Humans Male Middle Aged Self Report Treatment Adherence and Compliance Tuberculosis, Multidrug-Resistant - drug therapy |
| Title | Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31513073 https://www.proquest.com/docview/2289575241 |
| Volume | 82 |
| WOSCitedRecordID | wos000509681700013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Ivho2dqkNn2SMhwbujJljuFLSXPRwWjnavUv-LM96YU9CYJ96EOgIaQnJ9-5fghdtR3ue8ZrE5v2j1RwZhkeSItSXzEmbcELSpbxgxeGbDLxh5XDLavSKmudWChqmQrjI285YBnAJHDh3M7fLcMaZaKrFYXGKmoQgDJGqr3JMooAd71fRJUpNVlztC6d873WY9AvWxdWD2jw9u8gs7hsutv_XeYO2qpgJg5KudhFKyrZQxuDKpC-j75HdYI5DuRbWfKHA0M8hIcFBs8wAEo1Ne4G3EkTUbZxwkW9rlzkr9aTygz0hLFRHquFyGcpDGCeSNzrj_Fy_mmC77_4Sz7LrdD4iq5xQduHS4aiA_TcvRt1elZFymAJ09vdcl0uCGMazi5pa1dqMHEVARNb28K9gdMubVfasRTC87jQ3NaUwnqNntAu47ZziNaSNFHHCAMyaHtg0hApCJWMxRLgkCMI4QD8RMyb6LLe4wiE3kQyeKLSPIuWu9xER-WPiuZld46IAIYxiuvkD1-fok0AQH6ZnHeGGhqOvDpH6-LzY5otLgppgnc4HPwAO2bT0A |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+Adherence+Among+Persons+Receiving+Concurrent+Multidrug-Resistant+Tuberculosis+and+HIV+Treatment+in+KwaZulu-Natal%2C+South+Africa&rft.jtitle=Journal+of+acquired+immune+deficiency+syndromes+%281999%29&rft.au=Stephens%2C+Fay&rft.au=Gandhi%2C+Neel+R&rft.au=Brust%2C+James+C+M&rft.au=Mlisana%2C+Koleka&rft.date=2019-10-01&rft.issn=1944-7884&rft.eissn=1944-7884&rft.volume=82&rft.issue=2&rft.spage=124&rft_id=info:doi/10.1097%2FQAI.0000000000002120&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1944-7884&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1944-7884&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1944-7884&client=summon |